KADIMASTEM LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 480 ILa | 0.00% |
|
+0.42% | -19.06% |
| 03-28 | Kadimastem Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-28 | IMC Announces Potential Reverse Merger With A Leading Clinical Cell Therapy Company | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 5.38M | - | - | - | - | - | |
| 122B | ||||||
| 116B | ||||||
| 27.03B | - | |||||
| 20.36B | - | |||||
| 15.91B | - |
- Stock Market
- Equities
- KDST Stock
- Charts Kadimastem Ltd
- Sector Chart
